vs
Krystal Biotech, Inc.（KRYS）与Rocket Lab Corp（RKLB）财务数据对比。点击上方公司名可切换其他公司
Rocket Lab Corp的季度营收约是Krystal Biotech, Inc.的1.7倍（$179.7M vs $107.1M），Krystal Biotech, Inc.净利率更高（48.0% vs -29.5%，领先77.4%），Rocket Lab Corp同比增速更快（35.7% vs 17.5%），Krystal Biotech, Inc.自由现金流更多（$75.4M vs $-114.2M），过去两年Krystal Biotech, Inc.的营收复合增速更高（53.8% vs 39.2%）
Krystal Biotech是一家处于临床阶段的生物技术企业，专注于研发和商业化针对罕见重症皮肤病的新型基因疗法，主要面向北美和欧洲市场，服务缺乏有效常规治疗方案的单基因皮肤病患者。
Rocket Lab是公开上市的航空航天制造商及发射服务提供商，旗下Electron轨道火箭主打小型卫星发射，截至2026年1月已成功完成超75次任务，是全球现役发射次数最多的小型运载火箭。公司还开发了Electron的亚轨道改型HASTE用作高超音速技术测试平台，下一代可复用中型运载火箭Neutron目前也在研发中。
KRYS vs RKLB — 直观对比
营收规模更大
RKLB
是对方的1.7倍
$107.1M
营收增速更快
RKLB
高出18.2%
17.5%
净利率更高
KRYS
高出77.4%
-29.5%
自由现金流更多
KRYS
多$189.6M
$-114.2M
两年增速更快
KRYS
近两年复合增速
39.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $107.1M | $179.7M |
| 净利润 | $51.4M | $-52.9M |
| 毛利率 | — | 38.0% |
| 营业利润率 | 41.5% | -28.4% |
| 净利率 | 48.0% | -29.5% |
| 营收同比 | 17.5% | 35.7% |
| 净利润同比 | 13.0% | -1.1% |
| 每股收益（稀释后） | $1.69 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KRYSRKLB
| Q4 25 | $107.1M | $179.7M | ||
| Q3 25 | $97.8M | $155.1M | ||
| Q2 25 | $96.0M | $144.5M | ||
| Q1 25 | $88.2M | $122.6M | ||
| Q4 24 | $91.1M | $132.4M | ||
| Q3 24 | $83.8M | $104.8M | ||
| Q2 24 | $70.3M | $106.3M | ||
| Q1 24 | $45.3M | $92.8M |
净利润KRYSRKLB
| Q4 25 | $51.4M | $-52.9M | ||
| Q3 25 | $79.4M | $-18.3M | ||
| Q2 25 | $38.3M | $-66.4M | ||
| Q1 25 | $35.7M | $-60.6M | ||
| Q4 24 | $45.5M | $-52.3M | ||
| Q3 24 | $27.2M | $-51.9M | ||
| Q2 24 | $15.6M | $-41.6M | ||
| Q1 24 | $932.0K | $-44.3M |
毛利率KRYSRKLB
| Q4 25 | — | 38.0% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 32.1% | ||
| Q1 25 | — | 28.8% | ||
| Q4 24 | — | 27.8% | ||
| Q3 24 | — | 26.7% | ||
| Q2 24 | — | 25.6% | ||
| Q1 24 | — | 26.1% |
营业利润率KRYSRKLB
| Q4 25 | 41.5% | -28.4% | ||
| Q3 25 | 42.3% | -38.0% | ||
| Q2 25 | 40.9% | -41.3% | ||
| Q1 25 | 41.0% | -48.3% | ||
| Q4 24 | 45.4% | -38.9% | ||
| Q3 24 | 26.8% | -49.5% | ||
| Q2 24 | 12.2% | -40.7% | ||
| Q1 24 | -14.8% | -46.4% |
净利率KRYSRKLB
| Q4 25 | 48.0% | -29.5% | ||
| Q3 25 | 81.2% | -11.8% | ||
| Q2 25 | 39.9% | -46.0% | ||
| Q1 25 | 40.5% | -49.5% | ||
| Q4 24 | 49.9% | -39.5% | ||
| Q3 24 | 32.4% | -49.6% | ||
| Q2 24 | 22.2% | -39.2% | ||
| Q1 24 | 2.1% | -47.7% |
每股收益（稀释后）KRYSRKLB
| Q4 25 | $1.69 | $-0.09 | ||
| Q3 25 | $2.66 | $-0.03 | ||
| Q2 25 | $1.29 | $-0.13 | ||
| Q1 25 | $1.20 | $-0.12 | ||
| Q4 24 | $1.53 | $-0.11 | ||
| Q3 24 | $0.91 | $-0.10 | ||
| Q2 24 | $0.53 | $-0.08 | ||
| Q1 24 | $0.03 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $496.3M | $1.0B |
| 总债务越低越好 | — | $152.4M |
| 股东权益账面价值 | $1.2B | $1.7B |
| 总资产 | $1.3B | $2.3B |
| 负债/权益比越低杠杆越低 | — | 0.09× |
8季度趋势，按日历期对齐
现金及短期投资KRYSRKLB
| Q4 25 | $496.3M | $1.0B | ||
| Q3 25 | $392.6M | $976.7M | ||
| Q2 25 | $353.8M | $688.1M | ||
| Q1 25 | $308.8M | $428.4M | ||
| Q4 24 | $344.9M | $419.0M | ||
| Q3 24 | $374.0M | $442.4M | ||
| Q2 24 | $345.8M | $496.8M | ||
| Q1 24 | $359.0M | $492.5M |
总债务KRYSRKLB
| Q4 25 | — | $152.4M | ||
| Q3 25 | — | $347.0M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $345.9M | ||
| Q4 24 | — | $345.4M | ||
| Q3 24 | — | $61.2M | ||
| Q2 24 | — | $64.2M | ||
| Q1 24 | — | $66.8M |
股东权益KRYSRKLB
| Q4 25 | $1.2B | $1.7B | ||
| Q3 25 | $1.1B | $1.3B | ||
| Q2 25 | $1.0B | $688.5M | ||
| Q1 25 | $984.7M | $431.3M | ||
| Q4 24 | $946.4M | $382.5M | ||
| Q3 24 | $885.8M | $419.8M | ||
| Q2 24 | $838.9M | $455.2M | ||
| Q1 24 | $799.2M | $478.9M |
总资产KRYSRKLB
| Q4 25 | $1.3B | $2.3B | ||
| Q3 25 | $1.2B | $2.2B | ||
| Q2 25 | $1.1B | $1.6B | ||
| Q1 25 | $1.1B | $1.3B | ||
| Q4 24 | $1.1B | $1.2B | ||
| Q3 24 | $982.3M | $1.2B | ||
| Q2 24 | $917.7M | $1.2B | ||
| Q1 24 | $853.3M | $1.2B |
负债/权益比KRYSRKLB
| Q4 25 | — | 0.09× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | 0.80× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $77.5M | $-64.5M |
| 自由现金流经营现金流 - 资本支出 | $75.4M | $-114.2M |
| 自由现金流率自由现金流/营收 | 70.4% | -63.6% |
| 资本支出强度资本支出/营收 | 2.0% | 27.6% |
| 现金转化率经营现金流/净利润 | 1.51× | — |
| 过去12个月自由现金流最近4个季度 | $188.9M | $-321.8M |
8季度趋势，按日历期对齐
经营现金流KRYSRKLB
| Q4 25 | $77.5M | $-64.5M | ||
| Q3 25 | $39.7M | $-23.5M | ||
| Q2 25 | $52.7M | $-23.2M | ||
| Q1 25 | $31.0M | $-54.2M | ||
| Q4 24 | $52.8M | $-2.4M | ||
| Q3 24 | $58.9M | $-30.9M | ||
| Q2 24 | $-4.2M | $-13.0M | ||
| Q1 24 | $15.9M | $-2.6M |
自由现金流KRYSRKLB
| Q4 25 | $75.4M | $-114.2M | ||
| Q3 25 | $38.0M | $-69.4M | ||
| Q2 25 | $50.8M | $-55.3M | ||
| Q1 25 | $24.8M | $-82.9M | ||
| Q4 24 | $52.0M | $-23.9M | ||
| Q3 24 | $57.8M | $-41.9M | ||
| Q2 24 | $-5.3M | $-28.3M | ||
| Q1 24 | $14.6M | $-21.8M |
自由现金流率KRYSRKLB
| Q4 25 | 70.4% | -63.6% | ||
| Q3 25 | 38.8% | -44.8% | ||
| Q2 25 | 52.9% | -38.3% | ||
| Q1 25 | 28.1% | -67.6% | ||
| Q4 24 | 57.1% | -18.1% | ||
| Q3 24 | 69.0% | -40.0% | ||
| Q2 24 | -7.5% | -26.7% | ||
| Q1 24 | 32.3% | -23.5% |
资本支出强度KRYSRKLB
| Q4 25 | 2.0% | 27.6% | ||
| Q3 25 | 1.7% | 29.6% | ||
| Q2 25 | 2.0% | 22.2% | ||
| Q1 25 | 7.0% | 23.4% | ||
| Q4 24 | 0.9% | 16.3% | ||
| Q3 24 | 1.2% | 10.5% | ||
| Q2 24 | 1.6% | 14.4% | ||
| Q1 24 | 2.8% | 20.7% |
现金转化率KRYSRKLB
| Q4 25 | 1.51× | — | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | 1.38× | — | ||
| Q1 25 | 0.87× | — | ||
| Q4 24 | 1.16× | — | ||
| Q3 24 | 2.17× | — | ||
| Q2 24 | -0.27× | — | ||
| Q1 24 | 17.05× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KRYS
暂无分部数据
RKLB
| Products | $94.0M | 52% |
| Transferred Over Time | $87.3M | 49% |
